Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-28 @ 9:00 AM
Study NCT ID:
NCT05216835
Status:
COMPLETED
Last Update Posted:
2025-10-02
First Post:
2022-01-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-04
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-19
First Submit QC Date:
None
Study First Post Date:
2022-02-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-28
Results First Submit QC Date:
None
Results First Post Date:
2025-05-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-18
Last Update Post Date:
2025-10-02
Last Update Post Date Type:
ESTIMATED